https://www.optimumcomms.com/wp-content/uploads/2025/09/AMS_Logo_300x180px-80x80Web_Logos.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-09-01 07:14:352025-09-01 09:07:31Advanced Medical Solutions Group plc – Notice of Interim Results
https://www.optimumcomms.com/wp-content/uploads/2025/09/AMS_Logo_300x180px-80x80Web_Logos.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-09-01 07:14:352025-09-01 09:07:31Advanced Medical Solutions Group plc – Notice of Interim Results
Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
London, UK – 28 August 2025 – Leucid Bio ("Leucid" or the…

Resolution Therapeutics to host virtual R&D webinar alongside world leading clinical hepatologists Prof. Jonathan Fallowfield and Dr. Elliot Tapper
Resolution leadership team joined by world leading clinical…

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy
New York, July 30, 2025 – KKR & Co. Inc., a leading global…

Novo Holdings participates in $372.5 million Series D financing of MapLight Therapeutics to advance differentiated CNS therapies
Financing to support Phase 2 trials of lead program for schizophrenia…

Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies
Leverages Kling’s technology to discover hard-to-find,…

Leriglitazone Marketing Authorization Application submitted for treatment of cerebral adrenoleukodystrophy has been validated by European Medicines Agency
Barcelona, Spain and Düsseldorf, Germany – 23 July 2025 – Minoryx…

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia
Avendran Naidu appointed Head of Commercial to lead new affiliate
CNS…

Sanofi to acquire next-generation vaccine biotech Vicebio for US$1.6 billion
Sanofi will gain access to Molecular Clamp technology that…

EIFO and the Novo Nordisk Foundation Acquire the World’s Most Powerful Quantum Computer
EIFO, the export and investment fund of Denmark, and the Novo…

Xeltis announces positive data for Xabg, its coronary artery bypass conduit, in EU clinical trial
Preliminary clinical data from Xabg, Xeltis’ coronary artery…

One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling
Funding will be used to establish the clinical utility of…

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Clinical trial with ATAC candidate HDP-101 in multiple myeloma…

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
Series A co-led by founding investor M Ventures and new lead…

Neuraxpharm and Dizlin Pharmaceuticals Announce Global Strategic Co-Development Agreement Bringing Next-Generation Drug-Device Therapy to Patients with Advanced Parkinson’s Disease
Infudopa SubC® is a user-friendly and minimally invasive alternative…

Jacob Falck Hansen appointed as Chief Executive Officer of Vesper Bio
Copenhagen, Denmark, 01 July 2025 – Vesper Bio ApS (“Vesper”…
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York